EMETOGENIC POTENTIAL OF PARENTERAL ANTICANCER AGENTS

Question 1

AC

Answer 1

Highly Emetogenic

AC- defined as any chemotherapy regimen that contains an anthracycline and cyclophosphamide

Question 2

Carboplatin

Answer 2

AUC ≥4 - Highly Emetic Risk

AUC <4 - Moderate emetic risk

Question 3

Carmustine

Answer 3

> 250 mg/m2 - High Emetic Risk

≤250 mg/m2 - Moderate Emetic Risk

Question 4

Cisplatin

Answer 4

High Emetic Risk

Question 5

Cyclophosphamide

Answer 5

> 1500 mg/m2 - High Emetic Risk

≤1500 mg/m2- Moderate Emetic Risk

Question 6

Dacarbazine

Answer 6

High Emetic Risk

Question 7

Doxorubicin

Answer 7

≥60 mg/m2 - High Emetic Risk

<60 mg/m2 - Moderate Emetic Risk

Question 8

Epirubicin

Answer 8

> 90 mg/m2 - High Emetic Risk

≤90 mg/m2 - Moderate Emetic Risk

Question 9

Ifosfamide

Answer 9

≥2 g/m2 per dose - High Emetic Risk

<2 g/m2 per dose - Moderate Emetic Risk

Question 10

Mechlorethamine

Answer 10

High Emetic Risk

Question 11

Melphalan

Answer 11

≥140 mg/m2 - High Emetic Risk

<140 mg/m2 - Moderate Emetic Risk

Question 12

Sacituzumab govitecan-hziy

Answer 12

High Emetic Risk

Question 13

Streptozocin

Answer 13

High Emetic Risk